Evaluation of the Effects of Different Doses of Ayahuasca on Intelligence and Verbal Memory in Healthy Volunteers: A Preliminary, Exploratory, Double-Blind, Randomized, Placebo-controlled Study.

IF 2.9 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Caio César de Paula, Anna B Vicentini, Lorena T L Guerra, Renan M Maekawa, José A Silva Reis, Bianca Villanova, Caroline C Gomes, Taini Bellucci, Giordano N Rossi, José C Bouso, Jaime E C Hallak, Rafael G Dos Santos
{"title":"Evaluation of the Effects of Different Doses of Ayahuasca on Intelligence and Verbal Memory in Healthy Volunteers: A Preliminary, Exploratory, Double-Blind, Randomized, Placebo-controlled Study.","authors":"Caio César de Paula, Anna B Vicentini, Lorena T L Guerra, Renan M Maekawa, José A Silva Reis, Bianca Villanova, Caroline C Gomes, Taini Bellucci, Giordano N Rossi, José C Bouso, Jaime E C Hallak, Rafael G Dos Santos","doi":"10.1097/JCP.0000000000002267","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Observational studies with ritual ayahuasca users suggest that experienced users tend to have better cognitive performance, while novice users may experience transient impairments, particularly in working memory. However, no randomized clinical trials have systematically evaluated the cognitive effects of ayahuasca in healthy volunteers.</p><p><strong>Procedures: </strong>This double-blind, randomized, placebo-controlled trial evaluated the effects of a single dose of ayahuasca on intelligence and verbal memory in 28 healthy volunteers. Participants were randomized to receive placebo (1.0 mL/kg) or ayahuasca at doses of 0.5, 1.0, or 1.5 mL/kg (n=7 per group). The Wechsler Abbreviated Scale of Intelligence and the Rey Auditory Verbal Learning Test were administered at baseline, 4 hours, and 21 days postadministration.</p><p><strong>Results: </strong>For intelligence, significant time effects were observed across multiple domains (P<0.05), but no group × time interactions were detected. For verbal memory, significant time effects were observed for total learning, immediate recall, delayed recall, recognition, and total learning (P<0.05). A significant group × time interaction was observed only for delayed recall (P=0.006), with post hoc analysis revealing that the placebo performed better than the 0.5 mL/kg ayahuasca group at 4 hours (P=0.006). No other interactions reached significance, and no effects persisted at 21 days.</p><p><strong>Conclusions: </strong>In this preliminary exploratory trial, we found no evidence that a single administration of ayahuasca produced significant or persistent changes in standardized measures of intelligence or verbal memory in healthy volunteers. These findings provide preliminary information regarding short-term tolerability and cognitive performance following controlled administration and may inform future adequately powered trials.</p>","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JCP.0000000000002267","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Observational studies with ritual ayahuasca users suggest that experienced users tend to have better cognitive performance, while novice users may experience transient impairments, particularly in working memory. However, no randomized clinical trials have systematically evaluated the cognitive effects of ayahuasca in healthy volunteers.

Procedures: This double-blind, randomized, placebo-controlled trial evaluated the effects of a single dose of ayahuasca on intelligence and verbal memory in 28 healthy volunteers. Participants were randomized to receive placebo (1.0 mL/kg) or ayahuasca at doses of 0.5, 1.0, or 1.5 mL/kg (n=7 per group). The Wechsler Abbreviated Scale of Intelligence and the Rey Auditory Verbal Learning Test were administered at baseline, 4 hours, and 21 days postadministration.

Results: For intelligence, significant time effects were observed across multiple domains (P<0.05), but no group × time interactions were detected. For verbal memory, significant time effects were observed for total learning, immediate recall, delayed recall, recognition, and total learning (P<0.05). A significant group × time interaction was observed only for delayed recall (P=0.006), with post hoc analysis revealing that the placebo performed better than the 0.5 mL/kg ayahuasca group at 4 hours (P=0.006). No other interactions reached significance, and no effects persisted at 21 days.

Conclusions: In this preliminary exploratory trial, we found no evidence that a single administration of ayahuasca produced significant or persistent changes in standardized measures of intelligence or verbal memory in healthy volunteers. These findings provide preliminary information regarding short-term tolerability and cognitive performance following controlled administration and may inform future adequately powered trials.

评价不同剂量死藤水对健康志愿者智力和言语记忆的影响:一项初步、探索性、双盲、随机、安慰剂对照研究。
背景:对仪式死藤水使用者的观察性研究表明,有经验的使用者往往有更好的认知表现,而新手使用者可能会经历短暂的损伤,特别是在工作记忆方面。然而,没有随机临床试验系统地评估死藤水对健康志愿者的认知影响。试验过程:这项双盲、随机、安慰剂对照试验评估了单剂量死藤水对28名健康志愿者智力和言语记忆的影响。参与者随机接受安慰剂(1.0 mL/kg)或剂量为0.5、1.0或1.5 mL/kg的死藤水(每组n=7)。韦氏智力简略量表和雷伊听觉语言学习测试分别在基线、给药后4小时和21天进行。结果:对于智力,在多个领域观察到显著的时间效应(结论:在这项初步的探索性试验中,我们没有发现证据表明单次施用死藤水对健康志愿者的智力或言语记忆的标准化测量产生显著或持续的变化。这些发现为控制用药后的短期耐受性和认知表现提供了初步信息,并可能为未来充分有力的试验提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
3.40%
发文量
231
审稿时长
4-8 weeks
期刊介绍: Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书